Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,610.62
(
-0.21%
)
US TECH 100
23,740.80
(
-0.23%
)
Dow Jones
46,091.03
(
-0.29%
)
Brent Oil
103.66
(
-2.74%
)
Bitcoin
70,372.66
(
-1.22%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 48
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: DewDiligence post# 66310

Wednesday, 09/17/2008 11:11:59 PM

Wednesday, September 17, 2008 11:11:59 PM

Post# of 257259
Infergen:

I am just glad Dan Welch sold it to Valeant for what in hindsight was great timing. I believe it held some potential in treatment failures particularly daily dosing (before Protease Inhibitors showed promise). I believe InterMune was to get a milestone upon completion of that (daily dosing) trial but I haven't kept up with what happened.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now